{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T06:34:20Z","timestamp":1782974060710,"version":"3.54.5"},"reference-count":72,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2024,4,19]],"date-time":"2024-04-19T00:00:00Z","timestamp":1713484800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Economics"],"published-print":{"date-parts":[[2024,12,31]]},"DOI":"10.1080\/13696998.2024.2339638","type":"journal-article","created":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T04:03:10Z","timestamp":1712289790000},"page":"644-652","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":11,"title":["Cost-effectiveness and impact on infections and associated antimicrobial resistance of 20-valent pneumococcal conjugate vaccine in US children previously immunized with PCV13"],"prefix":"10.1080","volume":"27","author":[{"given":"Mark H.","family":"Rozenbaum","sequence":"first","affiliation":[{"name":"Pfizer Inc","place":["Collegeville, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Huang","sequence":"additional","affiliation":[{"name":"Pfizer Inc","place":["Collegeville, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Cane","sequence":"additional","affiliation":[{"name":"Pfizer Inc","place":["Collegeville, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriano","family":"Arguedas","sequence":"additional","affiliation":[{"name":"Pfizer Inc","place":["Collegeville, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Chapman","sequence":"additional","affiliation":[{"name":"Evidera","place":["London, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desmond","family":"Dillon-Murphy","sequence":"additional","affiliation":[{"name":"Evidera","place":["London, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria J.","family":"Tort","sequence":"additional","affiliation":[{"name":"Pfizer Inc","place":["Collegeville, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenza","family":"Snow","sequence":"additional","affiliation":[{"name":"Pfizer Inc","place":["Collegeville, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Chilson","sequence":"additional","affiliation":[{"name":"Pfizer Inc","place":["Collegeville, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Farkouh","sequence":"additional","affiliation":[{"name":"Pfizer Inc","place":["Collegeville, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,4,19]]},"reference":[{"key":"e_1_3_6_2_1","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/14.4.801"},{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.001446"},{"key":"e_1_3_6_4_1","unstructured":"King L. Advisory Committee on Immunization Practices. Pediatric outpatient ARI visits and antibiotic us attributable to serotypes in higher valency PCVs; 2023 [cited 2023 Mar 6]. Available from: https:\/\/www.cdc.gov\/vaccines\/acip\/meetings\/downloads\/slides-2023-02\/slides-02-22\/Pneumococcal-03-King-508.pdf"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00937-20"},{"key":"#cr-split#-e_1_3_6_6_1.1","unstructured":"U.S. FDA Approves PREVNAR 20\u00ae Pfizer's 20-valent pneumococcal conjugate vaccine for infants and children. [Internet]. 2023 [updated 2023 Apr 27"},{"key":"#cr-split#-e_1_3_6_6_1.2","unstructured":"cited 2023 Jun 14]. Available from: https:\/\/www.pfizer.com\/news\/press-release\/press-release-detail\/us-fda-approves-prevnar-20r-pfizers-20-valent-pneumococcal"},{"key":"e_1_3_6_7_1","unstructured":"Centers for Disease and Control Prevention. Advisory Committee on Immunization Practices (ACIP) recommendations; 2023 [updated 2023 Sep 22; cited 2023 Oct 9]. Available from: https:\/\/www.cdc.gov\/vaccines\/acip\/recommendations.html"},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa917"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw067"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000081"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix310"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2016.1277300"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0177113"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2015.1118593"},{"issue":"43","key":"e_1_3_6_15_1","first-page":"1477","article-title":"Invasive pneumococcal disease and 13-valent pneumococcal conjugate vaccine (PCV13) coverage among children aged \u226459 months\u2013selected US regions, 2010\u20132011","volume":"60","author":"Centers for Disease Control Prevention","year":"2011","unstructured":"Centers for Disease Control Prevention. Invasive pneumococcal disease and 13-valent pneumococcal conjugate vaccine (PCV13) coverage among children aged \u226459 months\u2013selected US regions, 2010\u20132011. MMWR Morb Mortal Wkly Rep. 2011;60(43):1477\u20131481.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-020-01601-1"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.08.020"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwy219"},{"key":"e_1_3_6_19_1","unstructured":"Kobayashi M. Pneumococcal Vaccines Work Group considerations and next steps; 2022."},{"key":"e_1_3_6_20_1","unstructured":"Centers for Disease Control and Prevention. Guidance for health economics studies presented to the Advisory Committee on Immunization Practices (ACIP); 2019 [updated 2019 Oct 11; cited 2021 Dec]. Available from: https:\/\/www.cdc.gov\/vaccines\/acip\/committee\/downloads\/Economics-Guidance-for-ACIP-2019.pdf"},{"key":"#cr-split#-e_1_3_6_21_1.1","unstructured":"US Census Bureau. National demographic analysis tables 2020"},{"key":"#cr-split#-e_1_3_6_21_1.2","unstructured":"2021 [cited 2022 Nov 17]. Available from: https:\/\/www.census.gov\/data\/tables\/2020\/demo\/popest\/2020-demographic-analysis-tables.html"},{"key":"e_1_3_6_22_1","unstructured":"US Census Bureau. Total U.S. resident population by age sex and series; 2020 (in thousands)."},{"key":"e_1_3_6_23_1","unstructured":"Centers for Disease Control and Prevention. Active bacterial core surveillance report emerging infections program network Streptococcus pneumoniae 2019; 2019 [cited 2022 Nov 17]. Available from: www.cdc.gov\/abcs\/downloads\/SPN_Surveillance_Report_2019.pdf"},{"key":"e_1_3_6_24_1","volume-title":"Economic assessment of PCV15 & PCV20","author":"Stoecker C","year":"2021","unstructured":"Stoecker C, editor. Economic assessment of PCV15 & PCV20. Atlanta (GA): Advisory Committee on Immunization Practices Meeting; 2021."},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1500245"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix647"},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-018-3139-1"},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2021.106476"},{"key":"e_1_3_6_29_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7104a1"},{"key":"e_1_3_6_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.09.049"},{"key":"e_1_3_6_31_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.11.1460"},{"key":"e_1_3_6_32_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2004-2514"},{"key":"e_1_3_6_33_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7202a3"},{"key":"e_1_3_6_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(16)00052-7"},{"key":"e_1_3_6_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2022.05.011"},{"key":"e_1_3_6_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.10.060"},{"key":"e_1_3_6_37_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000232706.35674.2f"},{"key":"e_1_3_6_38_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-200209000-00005"},{"key":"e_1_3_6_39_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-200003000-00003"},{"key":"e_1_3_6_40_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2013.3924"},{"key":"e_1_3_6_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(16)30306-0"},{"key":"e_1_3_6_42_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw347"},{"key":"e_1_3_6_43_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0199989"},{"key":"e_1_3_6_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.06.062"},{"key":"e_1_3_6_45_1","unstructured":"Centers for Disease Control and Prevention. Active bacterial core surveillance: trends by serotype group; 2018 [cited 2022 Nov 17]. Available from: https:\/\/www.cdc.gov\/abcs\/reports-findings\/survreports\/spneu-types.html"},{"key":"e_1_3_6_46_1","unstructured":"Pfizer. ABCs confidential serotype-specific data file for the years 2000\u20132018."},{"key":"e_1_3_6_47_1","doi-asserted-by":"publisher","DOI":"10.1007\/s41669-020-00240-9"},{"key":"e_1_3_6_48_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-016-1432-4"},{"key":"e_1_3_6_49_1","doi-asserted-by":"publisher","DOI":"10.1101\/2023.08.24.23294570"},{"key":"e_1_3_6_50_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-020-02650-y"},{"key":"e_1_3_6_51_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2012-3350"},{"key":"e_1_3_6_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2004.05.003"},{"key":"e_1_3_6_53_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e6879"},{"key":"e_1_3_6_54_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-017-2302-3"},{"key":"e_1_3_6_55_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00325-2015"},{"key":"e_1_3_6_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0895-4356(02)00448-1"},{"key":"e_1_3_6_57_1","doi-asserted-by":"publisher","DOI":"10.1086\/322587"},{"key":"e_1_3_6_58_1","unstructured":"Pfizer. Prenar 20 (pneumococcal 20-valent conjugate vaccine) suspension for intramuscular injection prescribing information; 2021."},{"key":"e_1_3_6_59_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-12-175"},{"key":"e_1_3_6_60_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-017-0882-9"},{"key":"e_1_3_6_61_1","unstructured":"Centers for Disease and Control Prevention. Pneumococcal disease; 2020 [updated 2020 Sep 1; cited 2023 Jul 11]. Available from: https:\/\/www.cdc.gov\/pneumococcal\/about\/diagnosis-treatment.html"},{"key":"e_1_3_6_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)02724-0"},{"key":"e_1_3_6_63_1","unstructured":"Centers for Disease and Control Prevention. Antibiotic resistance threats in the United States 2019; 2019 [cited 2023 Mar 6]. Available from: https:\/\/www.cdc.gov\/drugresistance\/pdf\/threats-report\/2019-ar-threats-report-508.pdf"},{"key":"e_1_3_6_64_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1721095115"},{"key":"e_1_3_6_65_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofad098"},{"key":"e_1_3_6_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2019.10.005"},{"key":"e_1_3_6_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)69637-2"},{"key":"e_1_3_6_68_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c2509"},{"key":"e_1_3_6_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2011.10.015"},{"key":"e_1_3_6_70_1","unstructured":"Centers for Disease and Control Prevention. AR threats report; 2019 [cited 2023 Mar 21]. Available from: https:\/\/www.cdc.gov\/drugresistance\/biggest-threats.html"},{"key":"e_1_3_6_71_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11010135"}],"container-title":["Journal of Medical Economics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13696998.2024.2339638","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T06:38:09Z","timestamp":1772779089000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13696998.2024.2339638"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,19]]},"references-count":72,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12,31]]}},"alternative-id":["10.1080\/13696998.2024.2339638"],"URL":"https:\/\/doi.org\/10.1080\/13696998.2024.2339638","relation":{},"ISSN":["1369-6998","1941-837X"],"issn-type":[{"value":"1369-6998","type":"print"},{"value":"1941-837X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,19]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-02-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-02","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}